Research ArticleCANCER

Recruitment of CD103+ dendritic cells via tumor-targeted chemokine delivery enhances efficacy of checkpoint inhibitor immunotherapy

See allHide authors and affiliations

Science Advances  11 Dec 2019:
Vol. 5, no. 12, eaay1357
DOI: 10.1126/sciadv.aay1357

Article Information

vol. 5 no. 12

Online ISSN: 
History: 
  • Received for publication May 31, 2019
  • Accepted for publication October 21, 2019
  • .

Author Information

  1. John-Michael Williford1,*,
  2. Jun Ishihara1,*,
  3. Ako Ishihara1,
  4. Aslan Mansurov1,
  5. Peyman Hosseinchi1,
  6. Tiffany M. Marchell1,2,
  7. Lambert Potin1,3,
  8. Melody A. Swartz1,2,4 and
  9. Jeffrey A. Hubbell1,2,
  1. 1Pritzker School of Molecular Engineering, University of Chicago, Chicago, IL 60637, USA.
  2. 2Committee on Immunology, University of Chicago, Chicago, IL 60637, USA.
  3. 3Institute of Bioengineering, Ecole Polytechnique Fédérale de Lausanne, CH-1015 Lausanne, Switzerland.
  4. 4Ben May Department for Cancer Research, University of Chicago, Chicago, IL 60637, USA.
  1. Corresponding author. Email: jhubbell{at}uchicago.edu
  • * These authors contributed equally to this work.

Altmetric

Article usage

Article usage: December 2019 to January 2021

AbstractFullPdf
Dec 20193393621797
Jan 202062693193
Feb 202034313146
Mar 202042336168
Apr 202051305181
May 202040310152
Jun 20201920686
Jul 20202020798
Aug 20201926097
Sep 20202519486
Oct 202019224113
Nov 20201419175
Dec 20201821989
Jan 202119169120

Stay Connected to Science Advances

Navigate This Article